Sign in
NXL Stock Price, Chart, Stats & News
Nexalin Technology, Inc.
Save
Nexalin Technology, Inc. (NXL) does not currently pay a dividend.
6.79M
Market cap
–
Current P/E
–
Forward P/E
NXL chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -310.29% |
Operating margin | -2781.69% |
Pretax margin | -2725.76% |
Net margin | -2725.76% |
Effective tax rate | – |
ROA | -177.38% |
ROE | -195.71% |
D/E | – |
Interest coverage ratio | – |
NXL valuation
P/E | – |
P/S | 24.85x |
P/B | 1.81x |
P/CF | -1.37x |
P/FCF | -1.51x |
P/OCF | -1.37x |
PEG | -0.03x |
EV multiple | -0.99x |
About
Nexalin Technology, Inc. operates as a medical device firm specializing in the creation and advancement of neurostimulation therapies for mental health conditions in both the United States and China. The company commercializes its primary product, the Nexalin Device, which provides a non-invasive and drug-free treatment for anxiety and insomnia. This device functions by emitting a proprietary frequency-based waveform designed to elicit a beneficial response from mid-brain structures associated with various psychological disorders.
Similar securities
Based on sector and market capitalization
Report issue